Success Metrics

Clinical Success Rate

85.7%

Based on 6 completed trials

Completion Rate

86%(6/7)

Active Trials

1(13%)

Results Posted

50%(3 trials)

Terminated

1(13%)

Phase Distribution

Ph phase_4

25%

Ph not_applicable

50%

Ph phase_1

13%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution7 total trials

Phase 1Safety & dosage

1(14.3%)

Phase 4Post-market surveillance

2(28.6%)

N/ANon-phased studies

4(57.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

85.7%

6 of 7 finished

Non-Completion Rate

14.3%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(6)

Terminated(1)

Detailed Status

Completed6

Active, not recruiting1

Terminated1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

85.7%

Most Advanced

Phase 4

Trials by Phase

Phase 11 (14.3%)

Phase 42 (28.6%)

N/A4 (57.1%)

Trials by Status

completed675%

active_not_recruiting113%

terminated113%

Recent Activity

1 active trials

Showing 5 of 8

active_not_recruitingnot_applicable

Integrated HIV Prevention and HCV Care for PWID

NCT03981445

completednot_applicable

Community-based Cognitive Behavioral Therapy for Type 2 Diabetes

NCT04261361

completedphase_4

Pre-exposure Prophylaxis (PrEP) Adherence Enhancement Guided by iTAB and Drug Levels for Women

NCT02584140

completed

Effectiveness Of A Program That Includes Counseling And Patient Support On Adherence To Treatment With Lipitor

NCT01078285

terminatedphase_4

Study to Evaluate Whether a Medication Event Monitoring System (MEMS) Can Improve Adherence to Tecfidera Treatment in Multiple Sclerosis Patients.

NCT02343159

View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials

NCT03981445Not Applicable

Integrated HIV Prevention and HCV Care for PWID

Active Not Recruiting

NCT04261361Not Applicable

Community-based Cognitive Behavioral Therapy for Type 2 Diabetes

Completed

NCT02584140Phase 4

Pre-exposure Prophylaxis (PrEP) Adherence Enhancement Guided by iTAB and Drug Levels for Women

Completed

NCT01078285

Effectiveness Of A Program That Includes Counseling And Patient Support On Adherence To Treatment With Lipitor

Completed

NCT02343159Phase 4

Study to Evaluate Whether a Medication Event Monitoring System (MEMS) Can Improve Adherence to Tecfidera Treatment in Multiple Sclerosis Patients.

Terminated

NCT01359280Phase 1

Nurse Delivered Cell Phone Adherence Intervention (Pick It UP)

Completed

NCT00273780Not Applicable

Highly Active Antiretroviral Therapy (HAART) Adherence Interventions

Completed

NCT00781599Not Applicable

Improving Medication Compliance and Smoking Cessation Treatment Outcomes for African American Smokers

Completed

All 8 trials loaded

Drug Details

Intervention Type: BEHAVIORAL
Total Trials: 8